Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.
Deleporte A, Van den Eynde M, Forget F, Holbrechts S, Delaunoit T, Houbiers G, Kalantari HR, Laurent S, Vanderstraeten E, De Man M, Vergauwe P, Clausse M, Van Der Auwera J, D'Hondt L, Pierre P, Ghillemijn B, Covas A, Paesmans M, Ameye L, Awada A, Sclafani F, Hendlisz A.
Deleporte A, et al. Among authors: delaunoit t.
Cancer Med. 2021 Jul;10(13):4366-4374. doi: 10.1002/cam4.3976. Epub 2021 May 31.
Cancer Med. 2021.
PMID: 34057299
Free PMC article.
Clinical Trial.